Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 1,958.00
+17.70 (0.91%)
Oct 8, 2025, 3:30 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 322.43 billion as of October 8, 2025. Its market cap has increased by 6.28% in one year.
Market Cap
322.43B
Enterprise Value
296.04B
Revenue
57.20B
Ranking
n/a
PE Ratio
41.86
Stock Price
1,958.00
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 322.43B, an increase of 8.52%. That is a compound annual growth rate of 1.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 319.68B | 9.05% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | 382.04B | 28.59% |
| Nov 20, 2020 | 297.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,966.34B |
| Divi's Laboratories | 1,620.55B |
| Cipla | 1,222.39B |
| Apollo Hospitals Enterprise | 1,107.14B |
| Mankind Pharma | 1,023.93B |
| Zydus Lifesciences | 994.06B |
| Fortis Healthcare | 786.52B |
| Alkem Laboratories | 656.89B |